CSTL Latest News, Press Relases and Analysis

All

Press Releases

11 hours ago - By: Castle Biosciences, Inc.

Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer

11 hours ago - By: Castle Biosciences, Inc.

Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer

2 days ago - By: Zacks Investment Research - Mentions: SNY TEVA ANIP

TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia

3 days ago - By: Zacks Investment Research - Mentions: SNY ANIP KYMR

KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study

a month ago - By: Benzinga

Why Castle Biosciences' Rally Might Just Be Getting Started

a month ago - By: Benzinga

A Glimpse of Castle Biosciences's Earnings Potential

2 months ago - By: Castle Biosciences, Inc.

Castle Biosciences to Participate in Upcoming Investor Conferences

3 days ago - By: Zacks Investment Research - Mentions: AGIO ANIP CRMD

Agios Awaits Pyrukynd Decision in Thalassemia as FDA Misses Due Date

3 days ago - By: Castle Biosciences, Inc.

Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma

3 days ago - By: Castle Biosciences, Inc.

Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma

4 days ago - By: Zacks Investment Research

Here's Why 'Trend' Investors Would Love Betting on Castle Biosciences (CSTL)

21 days ago - By: Zacks Investment Research

Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable

22 days ago - By: Zacks Investment Research - Mentions: ALKS CRMD AVDL

ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal

22 days ago - By: Zacks Investment Research - Mentions: IDN PANL FSRL PRM

5 Stocks With Recent Price Strength Amid Wall Street Volatility

23 days ago - By: Zacks Investment Research - Mentions: ALKS INSM CRMD

Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri

24 days ago - By: Zacks Investment Research - Mentions: ALKS CRMD AVDL

Avadel Board Labels Lundbeck Acquisition Bid a Superior Proposal

25 days ago - By: Castle Biosciences, Inc.

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year

25 days ago - By: Castle Biosciences, Inc.

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year

26 days ago - By: Zacks Investment Research - Mentions: GLDD TILE PRM

Zacks.com featured highlights include Perimeter Solutions, Interface, Castle Biosciences and Great Lakes Dredge & Dock

a month ago - By: Zacks Investment Research - Mentions: GLDD TILE PRM

Forget the Fed, Bet on These 4 Stocks With Increasing Cash Flows

a month ago - By: Castle Biosciences, Inc.

New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

a month ago - By: Castle Biosciences, Inc.

New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

a month ago - By: Zacks Investment Research - Mentions: ATRO SABK PRM

Zacks.com featured highlights include Castle Biosciences, Perimeter Solutions, South Atlantic Bancshares and Astronics

a month ago - By: Castle Biosciences, Inc.

Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

a month ago - By: Castle Biosciences, Inc.

Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

a month ago - By: Zacks Investment Research - Mentions: ATRO SABK PRM

4 Stocks With Recent Price Strength to Enhance Your Portfolio

a month ago - By: SciBase

SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million

a month ago - By: Zacks Investment Research

Recent Price Trend in Castle Biosciences (CSTL) is Your Friend, Here's Why

a month ago - By: Zacks Investment Research - Mentions: ADCT

Castle Biosciences, Inc. (CSTL) Reports Q3 Loss, Tops Revenue Estimates

a month ago - By: Castle Biosciences, Inc.

Castle Biosciences Reports Third Quarter 2025 Results

a month ago - By: Castle Biosciences, Inc.

Castle Biosciences Reports Third Quarter 2025 Results

a month ago - By: Castle Biosciences, Inc.

Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic Dermatitis

a month ago - By: Castle Biosciences, Inc.

Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic Dermatitis

a month ago - By: Zacks Investment Research - Mentions: RDNT RAIL AVO

Forget Profit, Pick These 4 Stocks With Increasing Cash Flows

2 months ago - By: Castle Biosciences, Inc.

Castle Biosciences to Participate in Upcoming Investor Conferences

2 months ago - By: Castle Biosciences, Inc.

New Data at American College of Gastroenterology Annual Meeting Show TissueCypher® Provides Actionable Risk Insights that Influence Clinical Management and Prompt Risk-Aligned Intervention in Barrett’s Esophagus

2 months ago - By: Castle Biosciences, Inc.

New Data at American College of Gastroenterology Annual Meeting Show TissueCypher® Provides Actionable Risk Insights that Influence Clinical Management and Prompt Risk-Aligned Intervention in Barrett’s Esophagus

2 months ago - By: Castle Biosciences, Inc.

New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference

CASTLE BIOSCIENCES INC (CSTL) Stock News

CSTL Latest News, Press Relases and Analysis